APA (7th ed.) Citation

Choueiri, T., Eto, M., Kopyltsov, E., Rha, S., Porta, C., Motzer, R., . . . Powles, T. (2021). 660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update. Annals of Oncology, 32, S683. https://doi.org/10.1016/j.annonc.2021.08.056

Chicago Style (17th ed.) Citation

Choueiri, T.K, et al. "660P Phase III CLEAR Trial in Advanced Renal Cell Carcinoma (aRCC): Outcomes in Subgroups and Toxicity Update." Annals of Oncology 32 (2021): S683. https://doi.org/10.1016/j.annonc.2021.08.056.

MLA (9th ed.) Citation

Choueiri, T.K, et al. "660P Phase III CLEAR Trial in Advanced Renal Cell Carcinoma (aRCC): Outcomes in Subgroups and Toxicity Update." Annals of Oncology, vol. 32, 2021, p. S683, https://doi.org/10.1016/j.annonc.2021.08.056.